Number of patients on GLP-1, whether for diabetes or obesity, has tripled in the last three years thanks to Novo Nordisk and Eli Lilly
With such high demand for and short supply for GLP-1 agonists, some people have procured them from alternative sources, such as online vendors, medical spas, or compounding pharmacies selling products not evaluated by the FDA, some of which may contain different ingredients
Shen L, Keenan MJ, Martin RJ, Tulley RT, Raggio AM, McCutcheon KL, et al
First, they want treatment thats legitimate and compliant
Para viales de dosis mltiples, se requiere agua bacteriosttica para prevenir el crecimiento bacteriano entre usos
They were still losing at week 68